Zobrazeno 1 - 10
of 55
pro vyhledávání: '"J. G. Gribben"'
Autor:
Q. Heydt, C. Xintaropoulou, A. Clear, M. Austin, I. Pislariu, F. Miraki-Moud, P. Cutillas, K. Korfi, M. Calaminici, W. Cawthorn, K. Suchacki, A. Nagano, J. G. Gribben, M. Smith, J. D. Cavenagh, H. Oakervee, A. Castleton, D. Taussig, B. Peck, A. Wilczynska, L. McNaughton, D. Bonnet, F. Mardakheh, B. Patel
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
How the bone marrow microenvironment evolves during induction chemotherapy to facilitate acute lymphoblastic leukaemia (ALL) survival remains unclear. Here the authors show that adipocytes emergent during ALL therapy aid the survival of ALL cells thr
Externí odkaz:
https://doaj.org/article/5bd437ead45f4de29da3fc82c6989399
Publikováno v:
The Journal of Immunology. 159:3156-3167
Since TCR-mediated stimulation induces T cells to become sensitive to Fas-mediated activation-induced cell death (Fas-AICD), we examined whether anergized and CD28-costimulated T cell clones were equally sensitive to Fas-AICD. Here, we show that TCR
Publikováno v:
Leukemia & Lymphoma. 22:53-64
Publikováno v:
Research in Immunology. 146:140-149
Autor:
J M, Munro, A S, Freedman, J C, Aster, J G, Gribben, N C, Lee, K K, Rhynhart, J, Banchereau, L M, Nadler
Publikováno v:
Blood. 83:793-798
The B-lymphocyte/accessory-cell activation antigen B7 (BB1) has been shown in vitro to stimulate T-lymphocyte proliferation and cytokine production via CD28 present on the latter cells. In this study, benign lymphoid tissues, lymphomas, and extralymp
Autor:
Jon C. Aster, Arnold S. Freedman, Lee M. Nadler, K Rhynhart, JM Munro, N Lee, J Banchereau, J. G. Gribben
Publikováno v:
Blood. 83:793-798
The B-lymphocyte/accessory-cell activation antigen B7 (BB1) has been shown in vitro to stimulate T-lymphocyte proliferation and cytokine production via CD28 present on the latter cells. In this study, benign lymphoid tissues, lymphomas, and extralymp
Autor:
Robert J. Soiffer, Pearl Leavitt, Donna Neuberg, Geraldine S. Pinkus, J. G. Gribben, K Pesek, Heather Daley, Arnold S. Freedman, SN Rabinowe, John F. Daley
Publikováno v:
Blood. 82:1366-1376
Twenty patients with poor prognosis B-cell chronic lymphocytic leukemia (B-CLL) underwent uniform high-dose chemoradiotherapy followed by rescue with multiple monoclonal antibody-purged autologous bone marrow (BM) (12 patients) or T-cell-depleted all
Autor:
Arnold S. Freedman, K Pesek, S D Woo, Claude D. Gimmi, Neil L. Spector, F Coral, Donna Neuberg, Laura Saporito, J. G. Gribben, Michael Barber
Publikováno v:
Blood. 81:3449-3457
Although molecular biologic techniques can now detect minimal numbers of residual cancer cells in patients in complete clinical remission, the clinical significance of minimal residual disease has never been conclusively established. If the detection
Autor:
JA Taylor, C L Epstein, John M. Lambert, L Eliseo, Michael L. Grossbard, Walter A. Blattler, J Kinsella, Arnold S. Freedman, J. G. Gribben, SN Rabinowe
Publikováno v:
Blood. 81:2263-2271
Anti-B-blocked ricin (anti-B4-bR) combines the specificity of the anti- B4 (CD19) monoclonal antibody with the protein toxin “blocked ricin.” In blocked ricin, affinity ligands are attached to the ricin B-chain to attenuate its lectin binding cap
Autor:
J G, Gribben, L, Saporito, M, Barber, K W, Blake, R M, Edwards, J D, Griffin, A S, Freedman, L M, Nadler
Publikováno v:
Blood. 80:1083-1089
Using the extremely sensitive technique of polymerase chain reaction (PCR) to detect the bcl-2 translocation, only 50% of bone marrows could be purged of PCR-detectable lymphoma cells using a cocktail of three anti-B-cell monoclonal antibodies (MoAbs